Publikationen, an denen er mitarbeitet Francisco Campos Pérez (16)

2020

  1. Iron Deposits in Periaqueductal Gray Matter Are Associated with Poor Response to OnabotulinumtoxinA in Chronic Migraine

    Toxins, Vol. 12, Núm. 8

2019

  1. Iron deposition in periaqueductal gray matter as a potential biomarker for chronic migraine

    Neurology, Vol. 92, Núm. 10, pp. E1076-E1085

2015

  1. Study of Protein Expresion in Peri-Infarct Tissue after Cerebral Ischemia

    Scientific Reports, Vol. 5

2014

  1. Human recombinant glutamate oxaloacetate transaminase 1 (GOT1) supplemented with oxaloacetate induces a protective effect after cerebral ischemia

    Cell Death and Disease, Vol. 5, Núm. 1

  2. In vivo theranostics at the peri-infarct region in cerebral ischemia

    Theranostics, Vol. 4, Núm. 1, pp. 90-105

  3. Quick adjustment of imaging tracer payload, for in vivo applications of theranostic nanostructures in the brain

    Nanomedicine: Nanotechnology, Biology, and Medicine, Vol. 10, Núm. 4, pp. 851-858

  4. Regulatory T cells modulate inflammation and reduce infarct volume in experimental brain ischaemia

    Journal of Cellular and Molecular Medicine, Vol. 18, Núm. 8, pp. 1571-1579

2013

  1. Liposomes and nanotechnology in drug development: Focus on neurological targets

    International Journal of Nanomedicine, Vol. 8, pp. 951-960

2012

  1. Glutamate Excitoxicity Is the Key Molecular Mechanism Which Is Influenced by Body Temperature during the Acute Phase of Brain Stroke

    PLoS ONE, Vol. 7, Núm. 8

  2. Influence of temperature on ischemic brain: Basic and clinical principles

    Neurochemistry International

  3. Oxaloacetate: A novel neuroprotective for acute ischemic stroke

    International Journal of Biochemistry and Cell Biology

2011

  1. High blood glutamate oxaloacetate transaminase levels are associated with good functional outcome in acute ischemic stroke

    Journal of Cerebral Blood Flow and Metabolism, Vol. 31, Núm. 6, pp. 1387-1393

  2. Neuroprotection by glutamate oxaloacetate transaminase in ischemic stroke: An experimental study

    Journal of Cerebral Blood Flow and Metabolism, Vol. 31, Núm. 6, pp. 1378-1386

  3. Targeting the ischemic penumbra

    Stroke

  4. Toll-like receptors 7 and 8 expression is associated with poor outcome and greater inflammatory response in acute ischemic stroke

    Clinical Immunology, Vol. 139, Núm. 2, pp. 193-198

  5. Técnicas de imagen para el estudio de la recuperación funcional tras el ictus: I. Aspectos metodológicos

    Revista de Neurologia, Vol. 52, Núm. 6, pp. 355-365